focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.50
Ask: 4.50
Change: 0.49 (13.96%)
Spread: 1.00 (28.571%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome Appoints Geoffrey Ellis As Finance Director, Loss Widens

Tue, 30th Sep 2014 09:41

LONDON (Alliance News) - Proteome Sciences PLC said Tuesday that has appointed Geoffrey Ellis as Finance Director, and posted a slightly widened pretax loss for the half-year to the end of June.

Ellis previously acted as chief financial officer of The Walt Disney Co's Network of Disney Channels in Europe, the Middle East and Africa, and managing director Disney Channel Scandinavia, Middle East and Emerging Markets.

Ellis succeeds James Malthouse, who is retiring after 20 years with the company.

Proteome posted a pretax loss of GBP2.1 million, widened from a loss of GBP1.9 million a year before, as revenue declined to GBP784,276 from GBP885,475, and administrative expenses rose slightly to GBP2.5 million from GBP2.3 million.

The company said following the growth in licensing, services and sales of its Tandem Mass Tag reagents in 2013, its core technologies had continued to strengthen in the first-half of 2014. Some contracts it was expecting were delayed, however, and the company said because of their size it is difficult to predict when they will come through.

Proteome said that whilst it is "difficult to be precise" over the timing of these revenue contributions, the scale and number of contracts in its order book is "growing steady and that performance is expected to continue in 2015."

Sales of Tandem Mass Tag reagent's rose 98% compared to the previous year. Proteome expects to see a more significant contribution from the products in the second-half, as well as continued improvement in its revenues from licences, sales and services.

Last Friday the company announced "excellent" results from in vitro toxicity tests for its two lead compounds to treat Alzheimer's disease, which it hopes will attract pharmaceutical companies to partner with Proteome on the treatments.

Shares in Proteome are trading down 8.0% at 35.18 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 Jul 2020 17:54

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Ups Interest

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Ups Interest

Read more
26 Jun 2020 14:52

Proteome Sciences Outlook Positive; Sales Remain Stable In Five Months

Proteome Sciences Outlook Positive; Sales Remain Stable In Five Months

Read more
19 Jun 2020 16:04

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
22 Apr 2020 16:03

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
14 Apr 2020 14:30

Proteome Sciences 2019 Loss Narrows On Revenue Jump

Proteome Sciences 2019 Loss Narrows On Revenue Jump

Read more
30 Mar 2020 14:36

UK TRADING UPDATE SUMMARY: Kier To Reduce Salary For 6,500 Employees

UK TRADING UPDATE SUMMARY: Kier To Reduce Salary For 6,500 Employees

Read more
3 Mar 2020 15:41

DIRECTOR DEALINGS SUMMARY: TalkTalk Executive Chair Spends GBP400,000

DIRECTOR DEALINGS SUMMARY: TalkTalk Executive Chair Spends GBP400,000

Read more
11 Feb 2020 10:07

Proteome Sciences Raise 2019 Earnings Guidance After Boost In Sales

Proteome Sciences Raise 2019 Earnings Guidance After Boost In Sales

Read more
11 Feb 2020 08:10

Proteome Sciences posts stronger-than-expected Q4 sales

(Sharecast News) - Contract proteomics services provider Proteome Sciences said on Tuesday that it had recorded stronger-than-expected sales of TMT and TMTpro in the fourth quarter of 2019.

Read more
21 Jan 2020 11:18

Proteome Sciences Expects Narrowed Annual Loss On Revenue Growth

Proteome Sciences Expects Narrowed Annual Loss On Revenue Growth

Read more
31 Oct 2019 15:45

Proteome Sciences shares rocket after strong third quarter

(Sharecast News) - Proteome Sciences announced on Thursday that its services platform had continued to strengthen through the third quarter, during which a record number of 43 quotes for new business were issued.

Read more
31 Oct 2019 14:46

Proteome Says Services Platform Continues To Grow As CEO Departs

Proteome Says Services Platform Continues To Grow As CEO Departs

Read more
23 Oct 2019 10:48

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Read more
25 Jul 2019 12:33

Proteome Hails "Encouraging" Interim Progress As Loss Improves

(Alliance News) - Life sciences firm Proteome Sciences PLC said Thursday momentum continued to build in the first half of 2019, with losses improving after revenue jumped and costs fell.For

Read more
30 Apr 2019 17:25

Proteome Sciences Upbeat On Future After "Good" First Quarter

LONDON (Alliance News) - Proteome Sciences PLC, at its annual general meeting on Tuesday, said it experienced a "good" first quarter."As indicated in our recent results, we a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.